Four potential side-effects of cholesterol-lowering drugs statins
And although its prominence in conversation has died down somewhat in recent years, its importance is no less real, with 59% of people in the UK experiencing raised cholesterol in 2021. High levels of cholesterol was most evident in those aged 45 and 64 (72%) and among adults aged 16 to 33, men (53%) were more likely than women (46%) to have raised levels.
Now, a new study has also linked reduced levels of bad cholesterol with curbing the risk of dementia, finding that people with low-density lipoprotein (LDL-C) in their blood are 26% less likely to develop dementia and Alzheimer's disease.
It also looked at the use of statins – cholesterol-lowering medications – and found them to provide an "additional protective effect" against the condition.
Here, we take a look at what statins are, how they work – and the potential side-effects and benefits of the drug.
A group of medicines that help lower the level of LDL cholesterol – "bad cholesterol" – in the blood, statins are designed to reduce the production of it inside the liver.
The drugs are normally prescribed to those with potentially dangerous levels of LDL-C, which, in turn, can lead to the hardening and narrowing of the arteries and result in cardiovascular disease or atherosclerosis.
Coming in tablet form, statins are taken once daily, but the dose will depend on your medical needs. This dosage may also change over time, depending on what your GP deems necessary.
Most people have to continue taking statins throughout their life once they have been prescribed them.
Headaches
Dizziness
Nausea
Digestive problems, such as indigestion, diarrhoea or constipation
Muscle pain
Problems with sleep
Low blood platelet count
Feeling tired or physically weak
Muscle damage – This usually only happens when statins are taken in combination with other medication
Loss of sensation or tingling in the nerve endings
Tendon problems
Hair loss
Memory problems
Skins irritation
Loss of sex drive
Erectile dysfunction
Being sick
Liver damage
In addition to the 2025 study published in the Journal of Neurology, Neurosurgery & Psychiatry (outlined above), a 2016 study published by the same journal also linked statins to a lower risk of dementia and Alzheimer's.
Looking at 400,000 Medicare beneficiaries who used the drugs, the research found that men in the group who had taken the medication regularly for two years had a 12% lower risk of developing Alzheimer's.
Various studies have also looked at the impact statins have on cancer risks, but the results have been inconsistent and there's no conclusive answer right now. More research needs to be done to gauge whether statins can, indeed, lower the risk of certain cancers.
The drugs have also been found to reduce inflammation and irritation, and the exacerbation of atherosclerosis, which is a major cause of coronary artery disease (CAD).
Research published by Nature Communications in 2019 discovered a new link between statins and immune systems. It found that by using medications like statins, they could modify cell responses in the lab. Professor Andrew Cope, lead investigator of the study, said: "We think that our findings could explain why people taking statins are better at fighting influenza, and why patients have better outcomes for some types of cancer."
Read more about health conditions:
Seven health conditions you can visit your pharmacy for (Yahoo Life UK, 4-min read)
Seven chronic health conditions you've (probably) never heard of (Yahoo Life UK, 6-min read)
Six crucial things to learn about your health - before it's too late (Yahoo Life UK, 7-min read)
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Boston Globe
12 hours ago
- Boston Globe
Biogen sees potential in combining Alzheimer's and obesity drugs
Advertisement Biogen's looking to the growth of its Alzheimer's drug Leqembi to offset the decline of its multiple sclerosis franchise, which is facing competition from cheaper generic drugs. Biogen's new Alzheimer's drug is already facing competition from Eli Lilly & Co.'s Alzheimer's drug, which was approved in the US last year and has since captured around 30 percent of the market, according to analysts. Other companies are also circling. Novo is carrying out clinical trials to assess whether the main ingredient in diabetes drug Ozempic and weight-loss shot Wegovy might help people with early Alzheimer's disease. Research suggests that the weight-loss drug could slow Alzheimer's progression by impacting inflammation and vascular health. Results of Novo's late-stage trial are expected later this year. Advertisement Viehbacher noted that being overweight is a risk factor for Alzheimer's. He cautioned the Novo study 'is a fairly risky proposition,' adding that 'most of the experts we're talking to are not convinced that it will work.' 'It's logical if you have a weight-loss drug that you can see some benefit, but it's actually pretty hard to move the needle on the cognitive side,' Viehbacher added. Alzheimer's drug development has been riddled with failures, even when drugs looked promising in early studies. Leqembi is a partnership between Cambridge, Massachusetts-based Biogen and Japanese drugmaker Eisai Co. Biogen makes the active ingredient for Leqembi in Switzerland. The company then ships it to North Carolina, where it gets made into a product. President Donald Trump recently put a 39 percent tariff on imports from Switzerland. It's unclear whether this would impact Biogen's drug. Still, Viehbacher said the company has the ability to start producing the substance used to make Leqembi in North Carolina for the US market, while continuing to make it in Switzerland for outside the US. He said the company always intended to use its North Carolina facilities to make Leqembi and the potential move was not a direct response to Trump's tariff threats. Last month, Biogen announced it intends to invest an additional $2 billion in its existing manufacturing footprint in North Carolina's Research Triangle Park.
18 hours ago
ABC News chief medical correspondent on how to be the CEO of your own health
From making doctor's appointments to managing insurance to getting lab work done, taking care of your health can feel like a full-time job. Though it can take time and effort, being one step ahead when it comes to your own health can make a huge difference in longevity and well-being, according to ABC News chief medical correspondent Dr. Tara Narula. Narula, a board-certified cardiologist, said she likes to encourage patients to be the so-called "CEO of their own health," meaning they know every detail of their health care and can make informed decisions alongside their medical providers. Read below for Narula's checklist on how to take charge of your health. Dr. Tara Narula's tips for becoming the CEO of your own health Be proactive in finding a doctor One of the most important factors in taking charge of your health is surrounding yourself with a medical team with whom you feel confident and comfortable. Tips for finding a doctor: - Ask friends, family, neighbors or co-workers for doctors they recommend. - If you're moving away or your current doctor is retiring, ask your doctor for a referral to a new doctor. - If you have insurance coverage, use the insurance company's website to search for a doctor near you who takes your insurance plan, or call your insurance company and ask for a list of doctors. - If you don't have insurance coverage, utilize resources like the National Association of Free & Charitable Clinics and community health centers, to help find free or low-cost care. - Many hospitals and clinics also offer patient assistant programs to help uninsured patients afford their care. - When interviewing doctors, ask things such as how the doctor can be reached in an emergency, whether the doctor takes phone calls or emailed questions from patients, and what days and hours the doctor sees patients. Arrive to doctor visits prepared It's important to provide your doctor with as much information as possible at each appointment. Items to bring to a doctor appointment: - Make sure you bring a photo ID and, if you have insurance coverage, your health insurance card. - Bring a list of your medical history, including past or current health conditions or surgeries, and an outline of your family history including conditions such as heart disease, stroke, cancer, diabetes, high blood pressure or cholesterol, and Alzheimer's disease. - Bring a list of your medicines and supplements, including over-the-counter medications you take on a regular basis. - Bring written notes describing the symptoms your experiencing, including the type of pain, how severe it is on a scale of 1 to 10, when the symptoms are happening and how often. - Consider bringing an advocate -- a trusted person like a friend, relative or neighbor -- to take notes on your behalf. Your local hospital, insurance company or employer may offer patient advocacy services as well. Ask your doctor follow up questions Since doctor appointments are typically just 15 to 20 minutes, write down the top questions you want to ask your doctor. Questions to consider asking your doctor include: - What could be causing my symptoms? - Which tests might help find the problem? - Am I due for any screening tests? - What are the benefits and risks of tests and treatment options? - What lifestyle changes can I make to prevent disease? - Can you explain my lab results? - What conditions might I be at risk for based on family history, and what are symptoms that might suggest I have them? Also make sure to ask your doctor questions about any lab work being done. Questions to consider asking your doctor about lab work include: - Ask when you should expect to receive your results and always request a printed version to be mailed to your home. - What do my test results mean? Ask for a clear explanation of what the numbers or findings indicate. - Are my test results normal? Clarify whether your results fall within the expected range for your age, sex and health status. - What do these specific numbers or findings mean? Don't hesitate to ask for clarification on any terms or values you don't understand. - How accurate are the results? Understand the reliability of the test and whether any factors could have affected the outcome. - What are the reference ranges? Ask about the typical values for the test and what it means when results fall outside those ranges. Seek a second opinion -- or even a third You should always feel empowered to get a second opinion and even a third opinion. You will likely hear very different perspectives -- and that's OK. For whatever condition you have, you need to find someone who specializes in your specific condition. What to bring to a new doctor when seeking an additional opinion: - First, provide the new doctor with a copy of your pathology report from any biopsy or surgery. If you had surgery, you also want to provide a copy of your operative report. - Make sure to have a summary of your doctor's current treatment plan to review with the new doctor. - Make sure to have a list of all your medications, doses and when you take them.
Fox News
20 hours ago
- Fox News
Study reveals why ‘super agers' maintain ‘outstanding memory' into their 80s
Many assume that memory loss and cognitive decline are an inevitable part of aging — but new research suggests that doesn't have to be the case. A 25-year study from Northwestern University analyzed the brains of "super agers" to determine what traits they share that may contribute to their mental resilience. "Super agers" are defined as people 80 and older who show "outstanding memory performance" that is on par with those who are three decades younger, according to the researchers. "'Super ager' is not a condition, but rather a term we defined at Northwestern on the basis of a score on a memory test over age 80," lead author Sandra Weintraub, a professor of psychiatry and behavioral sciences and neurology at the Northwestern University Feinberg School of Medicine, told Fox News Digital. "We were interested in memory aging because memory decline is the most common complaint in older adults. One can be 'super' in many ways, and this is just one." In the study, the researchers analyzed 79 brains that were donated by super agers and identified some key differences compared to those who "age typically." Some of the brains contained amyloid and tau proteins, which typically accumulate in people with Alzheimer's disease, while other brains showed no sign of these toxins. "Some super agers have very few of these proteins, so for some reason they don't manufacture them," Weintraub noted. "But we found some super agers' brains contained large numbers of these proteins, despite maintaining their cognitive health until death." This means there may be different biological pathways to super aging — "one resistance and the other resilience," she said. "If your relative is forgetful at age 80, it may not be part of aging, but of disease." With the resistance group, they don't make the plaques and tangles, Weintraub said. In the resilience group, they make them, but they don't have any impact on their brains. While "typically aging" brains show thinning of the cortex — which is the outer layer of the brain that helps with decision-making, motivation and regulation of emotions — the super agers' brains did not show this characteristic. Super agers were also found to have a greater number of "von economo neurons," which are brain cells that control social behavior. The researchers also found that this group had larger "entorhinal neurons," which are essential for powering memory, the release stated. In terms of behavior, the super agers were also found to be "highly social" with strong interpersonal relationships, according to the study findings. "There is the common assumption that aging implicitly brings cognitive decline and that loss of short-term memory is part of 'normal aging,'" lead author Sandra Weintraub, professor of psychiatry and neurology at Northwestern Medicine, told Fox News Digital. "The truth is that on average, cognitive test scores decline, but the variance among individuals within that average span gets larger and larger with age," she continued. "That means that loss is not inevitable, and that if your relative is forgetful at age 80, it may not be part of aging, but of disease." Christopher Weber, Ph.D., senior director of global science initiatives at the Alzheimer's Association in Chicago, was not involved in the study but commented on the "exciting" findings. "This increases our understanding of people's brains as they age and gives some insight into what makes some resilient or resistant to age-related brain changes," Weber told Fox News Digital. The study shows that super agers have "more preserved brain structure" that is similar to much younger adults, according to Weber. "The findings suggest that cognitive decline is not an inevitable part of aging — especially for individuals who have more protective factors that preserve brain health and cognition," he said. Weber pointed out, however, that the "super aging" study population is small and not representative of the real-world population. "They are primarily well-educated and White," he said. "Also, this group was self-selected into the study. These individuals may be more health-conscious or cognitively engaged than average older adults." Even so, the findings could help scientists create more — and better — strategies for treating and preventing cognitive decline, according to Weber. "The more we know about successful aging, the more opportunities we have to discover and create interventions to enhance resistance and resilience." To help reduce the risk factors that affect brain health, Weintraub said, "What is good for your heart is good for your brain." "What is good for your heart is good for your brain." "We know that adopting certain lifestyle changes will reduce the risk of a bad outcome, but are not guaranteed to eradicate it," she told Fox News Digital. "Having said that, eat well, sleep well, exercise, socialize and value social relationships, treat whatever condition you have that you can treat, and stay away from harmful substances." For more health articles, visit The study was supported by the Northwestern Alzheimer's Disease Research Center and the National Institute on Aging of the National Institutes of Health. The findings were published in Alzheimer's & Dementia: The Journal of the Alzheimer's Association.
